Ojha Utkarsh, Mohammed Raihan
Faculty of Medicine, Imperial College School of Medicine, Imperial College London, London, UK.
Department of Medicine, University of Cambridge, Cambridge, UK.
Med Devices (Auckl). 2018 Feb 2;11:51-56. doi: 10.2147/MDER.S155739. eCollection 2018.
As diabetes mellitus (DM) has approached pandemic proportions, the pressure for effective glycemic management is mounting. The starting point for managing and living well with DM involves early diagnosis and monitoring blood glucose levels. Therefore, self-monitoring of blood glucose (SMBG) can help patients maintain their blood glucose levels within the appropriate range. The general principle behind the current SMBG method involves a finger prick test to obtain a blood drop, which is applied onto a reagent strip and read by an automated device. Novel techniques are currently under evaluation to create the next generation of painless and accurate glucose monitoring for DM. We began by outlining how the emerging technology of the noninvasive glucose monitoring devices (NIGMDs) provides both economic and clinical benefits for health systems and patients. We further explored the engineering and techniques behind these upcoming devices. Finally, we evaluated how the NIGMDs disrupt the diabetic device care market and drive health care consumerism. We postulated that the NIGMDs play a pivotal role in the implementation of next generation of diabetes prevention strategies.
随着糖尿病（DM）已达到大流行程度，有效血糖管理的压力日益增大。管理糖尿病并良好生活的起点包括早期诊断和监测血糖水平。因此，自我血糖监测（SMBG）可帮助患者将血糖水平维持在适当范围内。当前SMBG方法背后的一般原理是通过手指针刺测试获取一滴血，将其滴在试剂条上并由自动设备读取。目前正在评估新技术，以创造下一代用于糖尿病的无痛且准确的血糖监测方法。我们首先概述了无创血糖监测设备（NIGMDs）的新兴技术如何为卫生系统和患者带来经济和临床益处。我们进一步探索了这些即将推出的设备背后的工程和技术。最后，我们评估了NIGMDs如何扰乱糖尿病设备护理市场并推动医疗保健消费主义。我们推测NIGMDs在实施下一代糖尿病预防策略中发挥着关键作用。
